Clinical Trials Logo

Recurrent Oral Cavity Adenoid Cystic Carcinoma clinical trials

View clinical trials related to Recurrent Oral Cavity Adenoid Cystic Carcinoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01604772 Active, not recruiting - Clinical trials for Recurrent Salivary Gland Carcinoma

Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

Start date: July 2012
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well Akt inhibitor MK2206 works in treating patients with progressive, recurrent, or metastatic adenoid cyst carcinoma (cancer). Akt inhibitor MK2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT01175980 Active, not recruiting - Tongue Carcinoma Clinical Trials

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

Start date: August 2010
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well vorinostat works in treating patients with adenoid cystic carcinoma that has come back (recurrent) or that has spread from where it started to nearby tissue or lymph nodes (locally advanced) or has spread to other places in the body (metastatic). Vorinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.